Researchers from the Federal University of Parana, Einstein Hospital Israelita, and Isospec Laboratories (Fort Lauderdale) have published new findings that detail the potential of cannabinoids in treating both episodic and chronic migraine. Using animal models, the team tested different cannabinoid compounds—including cannabidiol (CBD), cannabigerol (CBG), and low-dose tetrahydrocannabinol (THC)—to examine their impact on migraine-related pain …
Category: Studies
Marijuana Use Linked to Lower Opioid Needs During Surgery, Study Finds
A study published in the Journal of Opioid Management finds that patients who use marijuana require fewer opioids during surgery than nonusers, while showing no differences in other anesthesia-related needs. Researchers from Wake Forest University School of Medicine and Temple University conducted a retrospective chart review of 570 patients who underwent surgery with general anesthesia. …
Study: Cannabinoids Show Potential to Improve Survival and Reduce Organ Damage in Sepsis
“Cannabinoids are promising therapeutic targets in the treatment of sepsis, as they improved survival, and reduced inflammation and organ injury”, states a new study published by the journal Inflammation Research. Sepsis is responsible for roughly one in five deaths globally, yet treatment options remain limited to supportive care, notes the research team from the Federal …
Study Finds CBD Can Improve Sleep in Cancer Patients, Especially at Higher Doses
A study published this week by Clinical and Translational Oncology finds that cannabidiol (CBD) can provide meaningful improvements in sleep quality for cancer patients, particularly when taken at higher doses. Researchers from the University of Wisconsin–Madison examined data from 1,962 cancer patients enrolled in the Minnesota Medical Cannabis Program (MMCP) between 2015 and 2023, making …
Study: Cannabis Use Linked to Significantly Lower Risk of Alcohol-Associated Liver Disease
Cannabis use is associated with a lower risk of alcohol-associated liver disease, according to a new study published by the peer-reviewed journal Liver International. For the study, researchers from Virginia Commonwealth University, Western University and London Health Sciences Centre, University of California San Diego, and Pontificia Universidad Católica de Chile examined whether cannabis use impacts …
Long-Term Case Study Finds Cannabis-Based Medicine Improves Tourette Syndrome Symptoms in Children
Researchers from Hannover Medical School and the Medical University of Warsaw have published a study in Frontiers in Psychiatry detailing two rare long-term cases of cannabis-based medicine (CBM) used to treat Tourette syndrome (TS) in children. The report follows two male adolescents who began CBM treatment at the ages of 8 and 12. Both were …
Synergistic Effects of CBD and Beta-Caryophyllene May Help Treat Pain and Depression
According to the results of a new study, combining cannabidiol (CBD) with the terpene beta-caryophyllene (BCP) may be an effective treatment option for chronic pain and depression, two conditions researchers say frequently overlap but are often managed separately. The study, published in Pharmacological Research, used a chronic inflammatory pain model in mice, induced with Complete …
Study: New CBD Microemulsion Delivery System Improves Stability
A research team from the University of Florence has published a study in the International Journal of Pharmaceutics, detailing a new self-microemulsifying drug delivery system (SMEDDS) designed to improve the oral delivery of cannabidiol (CBD). The team constructed a pseudoternary phase diagram to identify optimal components, ultimately formulating a system using Capryol 90 and isopropyl …
Psilocybin May Help Slow Skin Aging, Study Finds
A new study published in Biochemistry and Cell Biology finds that psilocybin may offer protective effects against skin aging caused by high-glucose and high-lipid diets. Researchers at the University of Lethbridge found that psilocybin helped preserve cellular health in fibroblasts exposed to stress conditions linked to oxidative damage, inflammation, and collagen breakdown.
Study: CBD Reduces Pain and Itching in Children With Recessive Dystrophic Epidermolysis Bullosa
A study published today by the British Journal of Dermatology has found that cannabidiol (CBD) can significantly reduce pain and itching in children with recessive dystrophic epidermolysis bullosa (RDEB), a rare genetic disorder that causes fragile skin and chronic wounds. The study followed 10 patients between the ages of 2 and 17, all of whom …













